Flu Deaths Increase to 7 in San Diego County

San Diego, California - Another flu death was reported in San Diego County last week, bringing this season’s total to seven, the County Health and Human Services Agency announced.

NIH researcher presents encouraging results for gene therapy for severe sickle cell disease

San Diego, California - A scientist from the National Institutes of Health will present promising, early results from a human clinical trial testing a novel gene replacement therapy in people with severe sickle cell disease. Preliminary findings suggest that the approach has an acceptable level of safety and might help patients consistently produce normal red blood cells instead of the sickle-shaped ones that mark this painful, life-threatening disease.

Flu Spreads Easily at Holiday Parties and Family Events

San Diego, California - If you’re planning on attending a work gathering or holiday event, the County Health and Human Services Agency wants to make sure the only thing you give is gifts and not the flu.

Season’s Second Flu Death Reported in San Diego

San Diego, California - A 70-year-old woman is the second person to die from the flu in the region this season, the County Health and Human Services Agency announced today.

San Diego County Opens New Live Well Center in Oceanside

Oceanside, California - The County of San Diego opened the new North Coastal Live Well Health Center in Oceanside on Tuesday, offering behavioral health treatment and recovery services and resources for military and veterans.

FDA’s updates to Medical Device Safety Action Plan to enhance post-market safety

Washington, DC - In April of this year, the FDA released its Medical Device Safety Action Plan: Protecting Patients, Promoting Public Health, which described recent actions we’ve taken to enhance device safety and outlined our vision for how the agency can build on these initiatives to further assure the safety and effectiveness of medical devices. We continue to modernize our approach to device safety. After carefully considering public feedback, we’ll be announcing in a series of updates several important new actions that will help the FDA continue to enhance our nationwide post-market surveillance system; address new safety concerns that emerge once a device is on the market; and encourage innovations that lead to safer medical devices.